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ABSTRACT 
Gold organometallic compounds have been extensively investigated as potential anticancer metallodrugs and have shown 
a high potential regarding antiproliferative effects [Hickey, 2008; Andermark, 2016; Meyer, 2012; Schmidt, 2019]. 
Enhanced stability is a driving argument for the design of gold complexes with N-heterocyclic carbene (NHC) ligands. 
The more surprising is the lack of methods of pharmaceutical analytics for their stability and solution chemistry. Such 
analytical methods are important key elements for future metabolomic investigations and will help to ensure a better 
understanding of the biological behavior of the complexes [Kostiainen, 2003].   
We selected complexes of the type of alkynylgold(I)(NHC) for detailed stability studies by HPLC-DAD-MS, in 
comparison to the well-known antirheumatic drug Auranofin. A RP-based chromatographic method was established to 
separate possible degradation products of alkynylgold(I)(NHC) complexes. The stability studies were performed at 37°C 
over 24h using dimethylformamide (DMF), dimethyl sulfoxide (DMSO), water and Dulbecco`s modified eagle medium 
(DMEM) solutions of each compound. Furthermore, interaction experiments of alkynylgold(I)(NHC) complexes with 
acetylcysteine are under way with the same set-up as the stability tests [Albert 2012].       
ESI (+) and (-) ionisation with a quadrupole analyser was used for mass spectrometry. The first results indicate that 
alkynylgold(I)(NHC) complexes are stable in the analysed solvents with no significant changes in their AUCs [Fig 2].
INTRODUCTION 
N-heterocyclic carbene (NHC) ligands with their strong
σ-donating character can be coordinated well to several
transition metals. Specifically, gold(I) complexes have
been extensively investigated and have shown a high
potential regarding antiproliferative
effects [Hickey, 2008; Andermark, 2016; Meyer, 2012;
Schmidt, 2019]. The enhanced stability has been a
driving argument for the design of metal-NHC based
drugs. However, extended studies on their solution
chemistry and stability have not been frequently
performed and aspects of pharmaceutical analytics have
not been considered sufficiently. We selected complexes
of the type alkynylgold(I)(NHC) (Fig. 1) for detailed
stability studies by HPLC-DAD-MS, in comparison to
the well-known antirheumatic agent Auranofin.
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Figure 1: Structures of selected alkynylgold(I)(NHC) 
complexes 
On top of that an interaction experiment of 
alkynylgold(I)(NHC) complexes with acetylcysteine is 
under way with the same set-up as the stability tests. 
EXPERIMENTAL 
The stability studies were performed in four different 
solvents (DMF, dimethyl sulfoxide (DMSO), water and 
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Dulbecco`s modified eagle medium (DMEM)) and were 
carried out with an established HPLC method. The first 
step was to prepare a DMF stock solution, which was 
diluted with the respective solvent. For the stability tests 
in water and DMEM the organic solvent (DMF) amount 
had to be increased to 50% of the total volume because 
of the poor water solubility properties of the compounds. 
After transferring the solutions into the HPLC vials the 
incubation at 37°C was done in the auto-sampler unit of 
the HPLC. The time-dependent injection could be 
automated. For this study the injection was done after 
0h, 4h, 8h, 12h and 24h. 
The interaction experiment was performed in three 
different solvents: water, phosphate-buffered saline 
(PBS), 2-amino-2-(hydroxymethyl)propane-1,3-diol 
(Tris) buffer. Initially acetylcysteine and the 
alkynylgold(I)(NHC) complexes were characterized in 
the solvents mentioned above over a time period of 24 
hours. After the characterization an equimolar solution 
of acetylcysteine and each alkynylgold(I)(NHC) 
complex were prepared and incubated together at 37°C 
over 24 hours in the autosampler unit. The injections 
were automated and measured under the same 
conditions as the stability tests.      
DISCUSSION AND CONCLUSIONS 
Over the exposure time no significant peak changes 
were observed. Moreover, the peak areas remained 
unaltered over 24 hours. 
In the case of the interaction experiment a different 
behavior could be observed. In water the peak for the 
alkynylgold(I)(NHC) complex disappeared almost 
completely after 2h and a new peak with a much shorter 
retention time occurred in the chromatogram, which 
could be identified as Au(NHC)2+ by means of MS 
detection. A similar behavior can be observed in PBS 
and Tris buffer. In case of PBS the decrease of the main 
peak is much lower and even after 24h a significant 
amount of alkynylgold(I)(NHC) complex is still present 
in the sample. Almost the same behavior can be 
observed in Tris buffer, however, the effect is much less 
developed.   
NOMENCLATURE 
AUC area und curve 
DAD diode array detector 
DMEM Dulbecco`s modified eagle medium 
DMF  dimethylformamide 
DMSO dimethyl sulfoxide 
ESI  electrospray ionisation 
HPLC high performance liquid 
chromatography  
MS mass spectrometry 
NHC N-heterocyclic carbene
PBS phosphate-buffered saline 
Tris 2-Amino-2-(hydroxymethyl)propane-
1,3-diol
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